2025-04-13 23:09:31
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Pentokey Organy India Ltd Q2 FY2023 profit at Rs. 11.51 lakhs
Posted On : 2022-11-08 17:27:35( TIMEZONE : IST )
PENTOKEY ORGANY (INDIA) LTD. has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 1.1327 crores during the period ended September 30, 2022 as compared to Rs. 0.4308 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 0.1151 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. -0.0202 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 0.18 for the period ended September 30, 2022 as compared to Rs. -0.03 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 1.1327 crs | ₹0.4308 crs |  162.93% |
| Net Profit | ₹0.1151 crs | ₹-0.0202 crs | 669.80% |
| EPS | ₹0.18 | ₹-0.03 | 700.00% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 1.1327 crores during the period ended September 30, 2022 as compared to Rs.0.0543 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.0.1151 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.-0.0619 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.0.18 for the period ended September 30, 2022 as compared to Rs.-0.10 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 1.1327 crs | ₹0.0543 crs | 1,986.00% |
| Net Profit | ₹0.1151 crs | ₹-0.0619 crs | 285.95% |
| EPS | ₹0.18 | ₹-0.10 | 280.00% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.1.5634 crores during the 6 Months period ended September 30, 2022 as compared to Rs.0.0893 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.0.0949 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.-0.19 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.0.15 for the 6 Months period ended September 30, 2022 as compared to Rs.-0.30 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹1.5634 crs | ₹0.0893 crs | 1,650.73% |
| Net Profit | ₹0.0949 crs | ₹-0.19 crs | 149.95% |
| EPS | ₹0.15 | ₹-0.30 | 150.00% |
Shares of PENTOKEY ORGANY (INDIA) LTD. was last trading in BSE at Rs. 20.00 as compared to the previous close of Rs. 20.65. The total number of shares traded during the day was 192 in over 4 trades.
The stock hit an intraday high of Rs. 20.65 and intraday low of 20.00. The net turnover during the day was Rs. 3921.00.
